LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5078 | 5588 | 0.9088 | 0.8937 |
BT-20 | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 4497 | 5588 | 0.8051 | 0.7670 |
BT-20 | CP724714 | 10 | uM | LJP5 | 72 | hr | 1657 | 3680 | 5588 | 0.6587 | 0.5760 |
BT-20 | Alvocidib | 0.12 | uM | LJP6 | 72 | hr | 1657 | 1396 | 5383 | 0.2596 | -0.0960 |
BT-20 | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 1657 | 1244 | 5383 | 0.2310 | -0.1561 |
BT-20 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1657 | 5718 | 5588 | 1.0234 | 1.0266 |
BT-20 | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5585 | 5588 | 0.9996 | 0.9994 |
BT-20 | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 1657 | 4763 | 5588 | 0.8525 | 0.8258 |
BT-20 | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 4547 | 5588 | 0.8139 | 0.7783 |
BT-20 | AT-7519 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 4313 | 5383 | 0.8018 | 0.7564 |
BT-20 | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 1889 | 5383 | 0.3511 | 0.0799 |
BT-20 | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1217 | 5383 | 0.2261 | -0.1671 |
BT-20 | AT-7519 | 10 | uM | LJP6 | 72 | hr | 1657 | 922 | 5383 | 0.1714 | -0.2941 |
BT-20 | AZD7762 | 1.11 | uM | LJP6 | 72 | hr | 1657 | 2517 | 5383 | 0.4683 | 0.2793 |
BT-20 | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1552 | 5383 | 0.2891 | -0.0378 |
BT-20 | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 1657 | 2584 | 5383 | 0.4793 | 0.2957 |
BT-20 | AZD8055 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 2341 | 5383 | 0.4347 | 0.2245 |
BT-20 | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1826 | 5383 | 0.3392 | 0.0581 |
BT-20 | AZD8055 | 10 | uM | LJP6 | 72 | hr | 1657 | 1508 | 5383 | 0.2798 | -0.0557 |
BT-20 | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 1657 | 4954 | 5383 | 0.9204 | 0.9040 |
BT-20 | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 1657 | 4847 | 5383 | 0.8995 | 0.8778 |
BT-20 | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5575 | 5588 | 0.9979 | 0.9971 |
BT-20 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1657 | 5847 | 5588 | 1.0463 | 1.0523 |
BT-20 | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 1657 | 3476 | 5383 | 0.6456 | 0.5456 |
BT-20 | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 1657 | 4886 | 5383 | 0.9077 | 0.8892 |